MAIA Biotechnology, Inc. (MAIA)
1.44
+0.09
(+6.67%)
USD |
NYAM |
Aug 25, 14:33
MAIA Biotechnology Total Assets (Quarterly) : 28.24M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.24M |
| March 31, 2026 | 35.32M |
| December 31, 2025 | 9.705M |
| September 30, 2025 | 11.78M |
| June 30, 2025 | 11.05M |
| March 31, 2025 | 11.86M |
| December 31, 2024 | 10.16M |
| September 30, 2024 | 9.243M |
| June 30, 2024 | 12.02M |
| March 31, 2024 | 8.716M |
| Date | Value |
|---|---|
| December 31, 2023 | 7.567M |
| September 30, 2023 | 7.001M |
| June 30, 2023 | 10.27M |
| March 31, 2023 | 9.074M |
| December 31, 2022 | 12.02M |
| September 30, 2022 | 14.78M |
| June 30, 2022 | 9.760M |
| March 31, 2022 | 11.44M |
| December 31, 2021 | 11.33M |
| September 30, 2021 | 11.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| TG Therapeutics, Inc. | 1.640B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.565M |
| Shareholders Equity (Quarterly) | 20.68M |
| Current Ratio | 4.512 |